Published online Aug 28, 2022. doi: 10.3748/wjg.v28.i32.4716
Peer-review started: April 6, 2022
First decision: June 27, 2022
Revised: July 15, 2022
Accepted: July 31, 2022
Article in press: July 31, 2022
Published online: August 28, 2022
Processing time: 141 Days and 21.9 Hours
Conventional ultrasound is the first imaging choice for liver diseases with the diagnostic efficiency not good enough, which promotes the development of new ultrasound technologies, such as contrast enhanced ultrasound and ultrasound elastography. Two dimensional shear wave elastography (2D-SWE) is convenient, less time-consuming and inexpensive. SWE plays an important role in the assessment of liver fibrosis and in the differential diagnosis of benign and malignant focal liver lesions (FLLs). However, its value for the differential diagnosis among different types of malignant FLLs has not been proved.
Though the value of SWE for the differential diagnosis between malignant and benign FLLs was not widely recognized, our previous study showed promising results using maximal elasticity (Emax) as the parameter to differentiate malignant FLLs from benign ones. As the clinical management and prognosis of different pathological types of malignant FLLs are different, it is important to diagnose accurately of the possible pathological types. So, it was necessary to explore the value of 2D-SWE with Emax in differential diagnosis of different pathological types of malignant FLLs.
We aim to explore the value of 2D-SWE using Emax in the differential diagnosis of FLLs, especially among different pathological types of malignant FLLs.
In this study, we diagnosed all FLLs as benign, malignant and undetermined using conventional ultrasound. And the stiffness of FLLs and the periphery of FLLs were evaluated using 2D-SWE and the quantitative parameter Emax. Emax of FLLs and the periphery of FLLs were compared between benign and malignant FLLs or among different pathological types of malignant FLLs.
There were totally 132 FFLs in 127 patients enrolled in the study, including 32 benign FLLs, 16 cholangiocellular carcinomas (CCCs), 72 hepatocellular carcinomas (HCCs) and 12 liver metastases. Thirty-five FLLs were diagnosed as undermined by conventional ultrasound. Emax of malignant FLLs (2.21 ± 0.57 m/s) were significantly higher than those of benign FLLs (1.59 ± 0.37 m/s) (P = 0.000). Emax of the periphery of malignant FLLs (1.52 ± 0.39 m/s) were significantly higher than those of benign FLLs (1.36 ± 0.44 m/s) (P = 0.040). The cut-off point of Emax of the tumors was 1.905 with AUC 0.843. The sensitivity, specificity and accuracy were 71.00%, 84.38% and 74.24% respectively using Emax > 1.905 m/s for diagnosis as malignant and 23 of 35 (65.74%) FLLs with undetermined diagnosis by conventional ultrasound were diagnosed correctly. Emax of liver metastases (2.73 ± 0.99 m/s) was significantly higher than that of primary liver carcinomas, including CCCs (2.14 ± 0.34 m/s) and HCCs (2.14 ± 0.46 m/s) (P = 0.002).
Malignant FLLs were stiffer than benign ones and liver metastases were stiffer than primary liver carcinomas. 2D-SEW with Emax was a useful complement to conventional ultrasound for the differential diagnosis of FLLs.
In this study, we demonstrated the differences of 2D-SWE with Emax between benign and malignant FLLs and among different pathological types of malignant FLLs. Prospective study to explore the value of 2D-SWE with Emax in the evaluatation the different stiffness of liver metastases from different sources or the different stiffness of HCC with different microvascular invasion grade will be necessary.